Sveriges mest populära poddar

Lytix Biopharma – Innovations in Killing Cancer

17 min•7 mars 2024

Following recent encouraging interim clinical results, hear Øystein Rekdal, CEO of Lytix Biopharma, discuss with Optimum's Nick Bastin how the company's lead candidate LTX-315 has a unique approach to killing cancer.

Hosted on Acast. See acast.com/privacy for more information.

Fler avsnitt av Optimum Perspectives

How sleep architecture shapes brain health: new frontiers in Alzheimer’s research

13 mars•20 min

Closing the gap on rare diseases in 2026

26 feb.•19 min

Why who funds science matters

11 feb.•27 min

Tackling the threat of AMR

13 nov. 2025•31 min

The ups and downs of ADCs – where to now?

3 nov. 2025•30 min

Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease

5 aug. 2025•23 min

Q&A with Professor Ali Tavassoli of Curve Therapeutics: RSC Interdisciplinary Prize winner 2025

25 juni 2025•24 min

Stronger together: changing the future of muscle wasting condition

28 feb. 2025•30 min

How bioengineered spider silk-based proteins are changing the world

6 feb. 2025•12 min

How to have a perfect IPO on NASDAQ

23 jan. 2025•24 min

Optimum Perspectives med Optimum Strategic Communications finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.